BAL Lazio

HTA

HTA – Risorse

Pubblicato lunedì 5 Maggio 2014

Risorse generali e reti internazionali

European network for Health Technology Assessment (EUNETHTA)
Health Technology Assessment Database (Cochrane)
Health Technology Assessment international (HTAi)
International Information Network on New and Emerging Health Technologies (EuroScan)
International Network of Agencies of Health Technology Assessment (INAHTA)

EUROPA

Italia
Agenzia nazionale per i servizi sanitari regionali (Age.Na.S.)
Società Italiana di Health Technology Assessment (SIHTA)

Austria
Ludwig Boltzmann Institut für Health Technology Assessment (LBI of HTA)

Belgio
Belgian Federal Health Care Knowledge Centre (KCE)

Danimarca
Danish Institute for Health Services Research (DSI)

Finlandia
Finnish Office for Health Technology Assessment (FinOHTA)

Francia
Comité d´Evaluation et de Diffusion des Innovations Technologiques (CEDIT)
Haute Autorité de Santé (HAS)

Germania
German Agency for HTA at the German Institute for Medical Documentation and Information (DAHTA @DIMDI)
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)

Lettonia
Health Statistics and Medical Technologies State Agency (VSMTVA)

Lituania
State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania (VASPVT)

Norvegia
Norwegian Knowledge Centre for the Health Services (NOKC)

Paesi Bassi
Gezondheidsraad (GR)
The Medical and Health Research Council of The Netherlands (ZonMw)

Polonia
Agency for Health Technology Assessment in Poland (AHTAPol)

Regno Unito
Centre for Reviews and Dissemination (CRD)
Institute of Applied Health Sciences (IAHS)
National Institute for Health Research Health Technology Assessment Programme
Quality Improvement Scotland (NHS QIS)

Spagna
Agencia de Evaluación de Tecnologias Sanitarias (AETS)
Andalusian Agency for Health Technology Assessment (AETSA)
Galician Agency for Health Technology Assessment (AVALIA-T)
Catalan Agency for Health Technology Assessment and Research (CAHTA)
Basque Office for Health Technology Assessment (OSTEBA)

Svezia
Swedish Council on Technology Assessment in Health Care (SBU)

Svizzera
Medical Technology Unit – Swiss Federal Office of Public Health (MTU-SFOPH)

RESTO DEL MONDO

Argentina
Institute for Clinical Effectiveness and Health Policy (IECS)

Australia
Adelaide Health Technology Assessment (AHTA)
Medical Services Advisory Committee (MSAC)

Brasile
Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Ciência e Tecnologia (DECIT-CGATS)

Canada
Agence d´Évaluation des Technologies et des Modes d´Intervention en Santé (AETMIS)
Canadian Agency for Drugs and Technologies in Health (CADTH)
Institute of Health Economics (IHE)

Malesia
Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)

Messico
Centro Nacional de Excelencia Tecnológica en Salud (CENETEC)

Nuova Zelanda
Health Services Assessment Collaboration (HSAC)

Taiwan
Center for Drug Evaluation (CDE)

USA
Agency for Healthcare Research and Quality (AHRQ)

Archiviato in ,

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

Accedi agli articoli

Ouldali N et al. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA. February 1, 2021. Epub ahead of print. doi:10.1001/jama.2021.0694

Freedman RA et al. Individualizing surveillance mammography for older patients after treatment for early-stage breast cancer: multidisciplinary expert panel and International Society of Geriatric Oncology Consensus Statement. JAMA Oncol. Published online January 28, 2021. doi:10.1001/jamaoncol.2020.7582

Fontanella CA et al. Association of cannabis use with self-harm and mortality risk among youths with mood disorders. JAMA Pediatr. Published online January 19, 2021. doi:10.1001/jamapediatrics.2020.5494

Goldenberg JZ et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 2021;372:m4743

Huang J, Yang F, Chien W, et al. Risk of substance use disorder and its associations with comorbidities and psychotropic agents in patients with autism. JAMA Pediatr. Published online January 04, 2021.

Ezekowitz JA et al. Is there a sex gap in surviving an acute coronary syndrome or subsequent development of heart failure? Circulation, 30 november 2020.

Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet 2019;394(10204):1159-68.

Vinogradova Y et al. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ 2020; 371 :m3873

Una finestra sull’open access

  • BMC Family Practice
  • BMC Medical Education
  • BMC Nursing
  • BMJ Open
  • PLOS Medicine

Reset della password

Per favore inserisci la tua email. Riceverai una nuova password via email.